Jakafi 20 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FCRV2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,589
Award facts
- Contract value 100% obligated
- $12,589.11 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,589.11 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 20 mg tablets (60-count units). Issued on January 20, 2026, with an ultimate completion date of January 21, 2026, this firm fixed-price delivery order carries no set-aside designation, indicating the award was made through unrestricted federal competition. DMS Pharmaceutical Group Inc. competed successfully against other qualified vendors to secure this pharmaceutical supply contract supporting Department of Defense healthcare operations.
This delivery order is issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499,999,999 contract awarded in November 2025 with performance extending through December 31, 2036. The PPV-G GEN V represents a component of the larger $30.3 billion federal pharmaceutical supply strategy designed to ensure consistent availability of branded and generic prescription medications, biologics, and medical consumables across Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group's established performance across numerous prior delivery orders demonstrates its capability as a critical pharmaceutical supplier within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FCRV2?
SPE2DR26FCRV2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FCRV2 worth?
The government has obligated $12,589 on SPE2DR26FCRV2.
Is contract SPE2DR26FCRV2 an order under another contract?
Yes. SPE2DR26FCRV2 is a delivery order under SPE2DR25D9168, an indefinite delivery contract.
Was contract SPE2DR26FCRV2 competed?
The extent of competition for SPE2DR26FCRV2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award